In this study, we aimed to clarify whether the lower expression of cell membrane localized NTCP could influence HBV de novo infection or reinfection, to examine the possible clinical implications of this phenomenon, and to explore the molecular mechanisms relevant to NTCP down-regulation in proliferating hepatocytes. The gene discussed is SLC10A1; the disease is infection.